{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:20:39Z","timestamp":1790655639889,"version":"4.1.0"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2025,1,1]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the potential of clinical factors, ultrasound findings, serum autoantibodies, and serum cytokine and chemokine profiles as predictors of clinical outcomes in rheumatoid arthritis (RA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and methods<\/jats:title>\n                  <jats:p>We included 200 patients with RA treated with biological and targeted synthetic disease-modifying antirheumatic drugs in a prospective multicentre ultrasound cohort study. Their serum levels of multiple cytokines and chemokines, rheumatoid factors, and serum autoantibodies (anti-cyclic citrullinated peptide-2 (anti-CCP2) and anti-carbamylated protein antibodies) were measured at baseline, 3 months and 12 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Dimensionality reduction using 38 cytokines and chemokines demonstrated four distinct clusters that differed significantly regarding the frequencies of remission defined by clinical composite measures and ultrasound evaluations. Prominent differences in IL-1\u03b2, IL-5, IL-7, IL-10, IFN\u03b3, GRO, IP-10, MCP-1 and MIP-1\u03b2 characterised the between-cluster differences. Two distinct groups made of four clusters showed a significant difference in IgM-anti-CCP2 positivity. The least absolute shrinkage and selection operator regression of 38 cytokines and chemokines for Clinical Disease Activity Index (CDAI) remission at 12 months resulted in the selection of MIP-1\u03b2. Logistic regression using baseline levels of anti-citrullinated protein antibody, IgM-anti-CCP2 positivity, the CDAI, the total power Doppler score, the cluster by cytokines and chemokines, MIP-1\u03b2, methotrexate dose and mechanisms of action revealed that cluster by cytokines and chemokines was the sole significant factor for CDAI remission at 12 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Specific patterns of cytokines and chemokines\u2014no other clinical factors and autoantibody profiles\u2014were important to distinguish patients with RA achieving remission at 12 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>UMIN000012524.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2024-005163","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T06:40:18Z","timestamp":1737787218000},"page":"e005163","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Distinct clinical outcomes based on multiple serum cytokine and chemokine profiles rather than autoantibody profiles and ultrasound findings in rheumatoid arthritis: a prospective ultrasound cohort study"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-4692","authenticated-orcid":false,"given":"Shoichi","family":"Fukui","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"},{"name":"Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Michitsuji","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"},{"name":"Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"},{"name":"Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Sumiyoshi","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"},{"name":"Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-4428","authenticated-orcid":false,"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-0757","authenticated-orcid":false,"given":"Naoki","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2429-7553","authenticated-orcid":false,"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-0929","authenticated-orcid":false,"given":"Tomoki","family":"Origuchi","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A J","family":"van Schie","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitaka","family":"Ueki","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Eiraku","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamami","family":"Yoshitama","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitomo","family":"Okada","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hamada","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ayano","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Tsuru","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-7520","authenticated-orcid":false,"given":"Tom W J","family":"Huizinga","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9618-6414","authenticated-orcid":false,"given":"Ren\u00e9 E M","family":"Toes","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ya","family":"Kawashiri","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"},{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study Group, Nagasaki, Japan"},{"name":"Center for Collaborative Medical Education and Development, Nagasaki University Institute of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"2025090312135684000_11.1.e005163.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"2025090312135684000_11.1.e005163.2","doi-asserted-by":"crossref","first-page":"102405","DOI":"10.1016\/j.jaut.2020.102405","article-title":"Precision medicine and management of rheumatoid arthritis","volume":"110","author":"Aletaha","year":"2020","journal-title":"J Autoimmun"},{"key":"2025090312135684000_11.1.e005163.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.02.004"},{"key":"2025090312135684000_11.1.e005163.4","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rkz002","article-title":"Predicting disease progression and poor outcomes in patients with moderately active rheumatoid arthritis: a systematic review","volume":"3","author":"Edwards","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"2025090312135684000_11.1.e005163.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.017574"},{"key":"2025090312135684000_11.1.e005163.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22279"},{"key":"2025090312135684000_11.1.e005163.7","first-page":"253","article-title":"Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope","volume":"26","author":"Lakos","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312135684000_11.1.e005163.8","doi-asserted-by":"crossref","DOI":"10.1186\/ar2449","article-title":"Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project","volume":"10","author":"Sv\u00e4rd","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"2025090312135684000_11.1.e005163.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1114465108"},{"key":"2025090312135684000_11.1.e005163.10","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/art.40237","article-title":"Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort","volume":"69","author":"Truchetet","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090312135684000_11.1.e005163.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31472-1"},{"key":"2025090312135684000_11.1.e005163.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.23667"},{"key":"2025090312135684000_11.1.e005163.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060635","article-title":"Development of a multi-biomarker disease activity test for rheumatoid arthritis","volume":"8","author":"Centola","year":"2013","journal-title":"PLoS One"},{"key":"2025090312135684000_11.1.e005163.14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes378"},{"key":"2025090312135684000_11.1.e005163.15","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/acr.23551","article-title":"Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease\u2010Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in Japan","volume":"70","author":"Nishino","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312135684000_11.1.e005163.16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/25785826.2020.1757920","article-title":"Non-TNF inhibitor switchers versus TNF inhibitor cyclers from multicentre rheumatoid arthritis ultrasonography prospective cohort in Japan","volume":"43","author":"Endo","year":"2020","journal-title":"Immunol Med"},{"key":"2025090312135684000_11.1.e005163.17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/03009742.2021.1876914","article-title":"Discrepancy between clinical and ultrasound remissions in rheumatoid arthritis: a multicentre ultrasound cohort study in Japan","volume":"50","author":"Endo","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"2025090312135684000_11.1.e005163.18","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023254","article-title":"Utility of a simplified ultrasonography scoring system among patients with rheumatoid arthritis: A multicenter cohort study","volume":"100","author":"Endo","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"2025090312135684000_11.1.e005163.19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026592","article-title":"Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA): A multicenter RA ultrasound prospective cohort in Japan","volume":"100","author":"Kawashiri","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"2025090312135684000_11.1.e005163.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-021-04392-5","article-title":"Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan","volume":"22","author":"Kawashiri","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"2025090312135684000_11.1.e005163.21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/03009742.2021.1927389","article-title":"Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan","volume":"51","author":"Endo","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"2025090312135684000_11.1.e005163.22","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000428","article-title":"Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system","volume":"3","author":"D\u2019Agostino","year":"2017","journal-title":"RMD Open"},{"key":"2025090312135684000_11.1.e005163.23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13075-021-02426-w","article-title":"Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission","volume":"23","author":"Terslev","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025090312135684000_11.1.e005163.24","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003328","article-title":"Type 17-specific immune pathways are active in early spondyloarthritis","volume":"9","author":"Hughes","year":"2023","journal-title":"RMD Open"},{"key":"2025090312135684000_11.1.e005163.25","unstructured":"Melville J , Lun A , Djekidel MN , et al . Package \u2018uwot. 2024."},{"key":"2025090312135684000_11.1.e005163.26","unstructured":"Csardi MG . Package \u2018igraph\u2019. 2013."},{"key":"2025090312135684000_11.1.e005163.27","doi-asserted-by":"publisher","DOI":"10.1088\/1742-5468\/2008\/10\/P10008"},{"key":"2025090312135684000_11.1.e005163.28","doi-asserted-by":"crossref","first-page":"107916","DOI":"10.1016\/j.csda.2023.107916","article-title":"Post-clustering difference testing: Valid inference and practical considerations with applications to ecological and biological data","volume":"193","author":"Hivert","year":"2024","journal-title":"Comput Stat Data Anal"},{"key":"2025090312135684000_11.1.e005163.29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression Shrinkage and Selection Via the Lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"Journal of the Royal Statistical Society Series B"},{"key":"2025090312135684000_11.1.e005163.30","unstructured":"Friedman J , Hastie T , Tibshirani R , et al . Package \u2018glmnet\u2019. CRAN R Repositary 2021;595."},{"key":"2025090312135684000_11.1.e005163.31","doi-asserted-by":"crossref","DOI":"10.1186\/ar4431","article-title":"Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers","volume":"16","author":"Ram\u00edrez","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025090312135684000_11.1.e005163.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu354"},{"key":"2025090312135684000_11.1.e005163.33","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.4049\/jimmunol.155.7.3660","article-title":"Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis","volume":"155","author":"Koch","year":"1995","journal-title":"J Immunol"},{"key":"2025090312135684000_11.1.e005163.34","doi-asserted-by":"publisher","DOI":"10.1186\/ar616"},{"key":"2025090312135684000_11.1.e005163.35","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1993.1153"},{"key":"2025090312135684000_11.1.e005163.36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2249.1995.tb03126.x","article-title":"Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells","volume":"101","author":"Robinson","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2025090312135684000_11.1.e005163.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214539"},{"key":"2025090312135684000_11.1.e005163.38","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.029751"},{"key":"2025090312135684000_11.1.e005163.39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-019-1815-0","article-title":"In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response","volume":"21","author":"de Moel","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025090312135684000_11.1.e005163.40","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1520-4"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2024-005163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:14:05Z","timestamp":1756926845000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2024-005163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,25]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/rmdopen-2024-005163"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2024-005163","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}